Published online April 23, 2007
PEDIATRICS Vol. 119 No. 5 May 2007, pp. e1149-e1158 (doi:10.1542/peds.2006-2425)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Russo, R. N.
Right arrow Articles by Haan, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Russo, R. N.
Right arrow Articles by Haan, E.
Related Collections
Right arrow Infectious Disease & Immunity
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

ARTICLE

Upper-Limb Botulinum Toxin A Injection and Occupational Therapy in Children With Hemiplegic Cerebral Palsy Identified From a Population Register: A Single-Blind, Randomized, Controlled Trial

Remo N. Russo, MBBS, FRACP, FAFRMa,b,c, Maria Crotty, FAFRM, PhDa,d, Michelle D. Miller, PhD, MNutrDiet, BScd, Sonya Murchland, BappSci, MHScc, Peter Flett, MBBS, FRACP, FACRM, FAFRM, MRACMAe and Eric Haan, BMedSc, MBBS, FRACPf

a Flinders University Department of Rehabilitation and Aged Care, Repatriation General Hospital, Daw Park, South Australia, Australia;
b Department of Child and Adolescent Development and Rehabilitation
f South Australian Clinical Genetics Service, Women's and Children's Hospital, North Adelaide, South Australia, Australia;
c Novita Children's Services, Regency Park, South Australia, Australia;
d Flinders Centre for Clinical Change and Health Care Research, Flinders University, Bedford Park, South Australia, Australia;
e Royal Hobart Hospital, Hobart, Tasmania, Australia

OBJECTIVES. The purpose of this work was to assess the effect of botulinum toxin A and occupational therapy compared with occupational therapy alone on body structure, activities participation, and self-perception in a sample of children (aged 3–16 years) with hemiplegic cerebral palsy recruited from a statewide register.

PATIENTS AND METHODS. Participants of this single-blind, randomized, controlled trial identified from a population-based cerebral palsy register received either an individually prescribed and localized injection of botulinum toxin A with 4 sessions of occupational therapy over 4 weeks (intervention) or occupational therapy alone (control). Outcomes were assessed from 2 domains of the World Health Organization International Classification of Functioning, Disability, and Health: body structure (Modified Ashworth Scale and Tardieu Scale) and activities participation (Assessment of Motor and Process Skills, Goal Attainment Scale, Pediatric Evaluation of Disability Inventory, and Pediatric Quality of Life Inventory). Self-perception was also measured.

RESULTS. All of the participants (intervention: n = 21; control: n = 22) provided data at baseline and 3 and 6 months. Mean age was 8.6 years; 23 were boys and 20 were girls. At 3 months, children allocated to receive the intervention performed significantly better in terms of body structure and activities participation. They reported improvements in self-perception for the global self-worth domain. At 6 months, the differences between the intervention and control groups persisted for the measures of body structure but not for activities participation or self-perception.

CONCLUSION. Botulinum toxin A injection combined with a low-intensity occupational therapy program achieves significant improvements in body structure, activity participation, and self-perception.


Key Words: botulinum toxin A • cerebral palsy • hemiplegia • child preschool • child • adolescent • disability evaluations • self-concept • randomized • controlled trial • upper extremity

Abbreviations: CP—cerebral palsy • BTX-A—botulinum toxin A • GAS—Goal Attainment Scaling • MAS—Modified Ashworth Scale • AMPS—Assessment of Motor and Process Skills • ADL—activities of daily living • PEDI—Pediatric Evaluation of Disability Inventory • PedsQL—Pediatric Quality of Life Inventory • SAE—serious adverse event • CI—confidence interval


Accepted Nov 1, 2006.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Clin RehabilHome page
C. Albavera-Hernandez, J. M Rodriguez, and A. J Idrovo
Safety of botulinum toxin type A among children with spasticity secondary to cerebral palsy: a systematic review of randomized clinical trials
Clinical Rehabilitation, May 1, 2009; 23(5): 394 - 407.
[Abstract] [PDF]


Home page
JBJSHome page
T. M. Seyler, B. P. Smith, D. R. Marker, J. Ma, J. Shen, T. L. Smith, M. A. Mont, K. Kolaski, and L. A. Koman
Botulinum Neurotoxin as a Therapeutic Modality in Orthopaedic Surgery: More Than Twenty Years of Experience
J. Bone Joint Surg. Am., November 1, 2008; 90(Supplement_4): 133 - 145.
[Full Text] [PDF]